Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- 🚴♀️ Register Early & Save—Gear Up Against Kids Cancer Ride
- Journal of Biological Chemistry: Phosphoregulation of RAD51AP1 function in homology-directed repair (Sung Lab)
- BioMolecules: The PELP1 Pathway and Its Importance in Cancer Treatment (Rao Lab)
- Frontiers: Editorial -Antioxidants in Mitigating Oxidative Stress-Induced Damage (Aune Lab)
- Dr. Raushan Kurmasheva’s laboratory has been awarded a $400K NCI SBIR Phase II grant titled “Enhanced overall survival in high-risk pediatric tumors using a novel oral small molecule.”
Events
Greehey CCRI Spring Seminar Series: Min Kyu Kim, PhD, MS (UTHSA)
Presentation title: “Regulation of BRCA-1 Phosphorylation in Genome Repair.”
Greehey CCRI Spring Seminar Series: Uttiya Basu, PhD (Columbia)
Presentation title: Somatic Hypermutation Mechanisms in B-Cell Immunity and Cancer
